Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.

NCT06851819 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer Extensive Stage

Interventions

RADIATION: radiotherapy
DRUG: immunechemotherapy

Sponsor

Hebei Medical University Fourth Hospital